Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630.

Asojo OA, Nelson SK, Mootien S, Lee Y, Rezende WC, Hyman DA, Matsumoto MM, Reiling S, Kelleher A, Ledizet M, Koski RA, Anthony KG.

Acta Crystallogr D Biol Crystallogr. 2014 Jul;70(Pt 7):1922-33. doi: 10.1107/S1399004714009419. Epub 2014 Jun 29.

2.

Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

Lee Y, Mootien S, Shoen C, Destefano M, Cirillo P, Asojo OA, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2013 Jul 15;86(2):222-30. doi: 10.1016/j.bcp.2013.05.004. Epub 2013 May 13.

3.

A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).

Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, Aristoff PA, Leng L, Koski RA, Powell TJ, Bucala R, Anthony KG.

J Biol Chem. 2012 Aug 31;287(36):30653-63. doi: 10.1074/jbc.M112.385583. Epub 2012 Jul 10.

4.

Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Ciustea M, Mootien S, Rosato AE, Perez O, Cirillo P, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2012 Feb 1;83(3):368-77. doi: 10.1016/j.bcp.2011.11.021. Epub 2011 Nov 29.

5.

New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.

Anthony KG, Strych U, Yeung KR, Shoen CS, Perez O, Krause KL, Cynamon MH, Aristoff PA, Koski RA.

PLoS One. 2011;6(5):e20374. doi: 10.1371/journal.pone.0020374. Epub 2011 May 26.

6.

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.

Sultana H, Foellmer HG, Neelakanta G, Oliphant T, Engle M, Ledizet M, Krishnan MN, Bonafé N, Anthony KG, Marasco WA, Kaplan P, Montgomery RR, Diamond MS, Koski RA, Fikrig E.

J Immunol. 2009 Jul 1;183(1):650-60. doi: 10.4049/jimmunol.0900093. Epub 2009 Jun 17.

7.

Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.

Anthony KG, Bai F, Krishnan MN, Fikrig E, Koski RA.

Antiviral Res. 2009 Jun;82(3):166-8. doi: 10.1016/j.antiviral.2008.12.007. Epub 2009 Jan 7.

PMID:
19135091
8.

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.

J Infect Dis. 2007 Dec 15;196(12):1741-8. doi: 10.1086/523654.

PMID:
18190253
9.

Mutational analysis of F-pilin reveals domains for pilus assembly, phage infection and DNA transfer.

Manchak J, Anthony KG, Frost LS.

Mol Microbiol. 2002 Jan;43(1):195-205.

11.

Epitopes fused to F-pilin are incorporated into functional recombinant pili.

Rondot S, Anthony KG, Dübel S, Ida N, Wiemann S, Beyreuther K, Frost LS, Little M, Breitling F.

J Mol Biol. 1998 Jun 12;279(3):589-603.

PMID:
9641980
12.

Analysis of the traLEKBP sequence and the TraP protein from three F-like plasmids: F, R100-1 and ColB2.

Anthony KG, Kathir P, Moore D, Ippen-Ihler K, Frost LS.

J Bacteriol. 1996 Jun;178(11):3194-200.

13.

The role of the pilus in recipient cell recognition during bacterial conjugation mediated by F-like plasmids.

Anthony KG, Sherburne C, Sherburne R, Frost LS.

Mol Microbiol. 1994 Sep;13(6):939-53.

PMID:
7854127

Supplemental Content

Loading ...
Support Center